ArticleBritish journal of cancer2014

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer.

T M A Abdel-Fatah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.